Elevated plasma endothelin-1 levels in diabetes mellitus.

[1]  B. Žižek,et al.  Endothelial dysfunction in hypertensive patients and in normotensive offspring of subjects with essential hypertension , 2001, Heart.

[2]  J. R. Mcneill,et al.  Plasma endothelin levels and vascular responses at different temporal stages of streptozotocin diabetes. , 1999, European journal of pharmacology.

[3]  G. D. Johnston,et al.  Endothelial function in offspring of Type 1 diabetic patients with and without diabetic nephropathy , 1999, Diabetic medicine : a journal of the British Diabetic Association.

[4]  Philip D. Harvey,et al.  Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39 , 1998, BMJ.

[5]  C. Ferri,et al.  Role of plasma and urinary endothelin-1 in early diabetic and hypertensive nephropathy. , 1998, American journal of hypertension.

[6]  B. Tarquini,et al.  Influence of non-insulin-dependent diabetes mellitus on plasma endothelin-1 levels in patients with advanced atherosclerosis. , 1998, Journal of diabetes and its complications.

[7]  T. Lüscher,et al.  Losartan but not verapamil inhibits angiotensin II-induced tissue endothelin-1 increase: role of blood pressure and endothelial function. , 1998, Hypertension.

[8]  J. Deanfield,et al.  Effect of enalapril on endothelial function in young insulin-dependent diabetic patients: a randomized, double-blind study. , 1998, Journal of the American College of Cardiology.

[9]  H. Krum,et al.  The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators. , 1998, The New England journal of medicine.

[10]  T. Lüscher,et al.  Angiotensin II Increases Vascular and Renal Endothelin-1 and Functional Endothelin Converting Enzyme Activityin Vivo:Role of ETAReceptors for Endothelin Regulation , 1997 .

[11]  E. Schiffrin,et al.  Clinical significance of endothelin in cardiovascular disease , 1997, Current opinion in cardiology.

[12]  S. Aksöyek,et al.  Plasma endothelin‐1 levels in non‐insulin dependent diabetes mellitus patients with macrovascular disease , 1997, Coronary artery disease.

[13]  G. Desideri,et al.  Effect of ACE Inhibition on Spontaneous and Insulin-Stimulated Endothelin-1 Secretion: In Vitro and In Vivo Studies , 1997, Diabetes.

[14]  J. Kastrup,et al.  Plasma endothelin in congestive heart failure: effect of the ACE inhibitor, fosinopril. , 1996, Cardiovascular research.

[15]  D. Guédin,et al.  Why are circulating concentrations of endothelin-1 so low? , 1994, Cardiovascular research.

[16]  C. G. Olthof,et al.  Plasma endothelin levels and vascular effects of intravenous L-arginine infusion in subjects with uncomplicated insulin-dependent diabetes mellitus. , 1994, Clinical science.

[17]  G. Pinna,et al.  Plasma Endothelin in NIDDM Patients With and Without Complications , 1994, Diabetes Care.

[18]  H. Teufelsbauer,et al.  Plasma big endothelin-1 concentrations in congestive heart failure patients with or without systemic hypertension. , 1993, The American journal of cardiology.

[19]  N. Iwasaki,et al.  Increased Plasma Endothelin in NIDDM Patients With Retinopathy , 1992, Diabetes Care.

[20]  B. Binder,et al.  Polar secretion of endothelin-1 by cultured endothelial cells. , 1992, The Journal of biological chemistry.

[21]  J. Leach,et al.  Plasma Endothelinlike Immunoreactivity Levels in IDDM Patients with Microalbuminuria , 1992, Diabetes Care.

[22]  P. Binkley,et al.  Plasma Endothelin Correlates With the Extent of Pulmonary Hypertension in Patients With Chronic Congestive Heart Failure , 1992, Circulation.

[23]  A. Lerman,et al.  Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. , 1991, The New England journal of medicine.

[24]  A. Lerman,et al.  Endothelin Has Biological Actions at Pathophysiological Concentrations , 1991, Circulation.

[25]  E. Schiffrin,et al.  Plasma endothelin in human essential hypertension. , 1991, American journal of hypertension.

[26]  K. Takahashi,et al.  Elevated plasma endothelin in patients with diabetes mellitus , 1990, Diabetologia.

[27]  W. Waldhäusl,et al.  Effect of endothelin-1 in man. , 1990, Circulation.

[28]  K. Nakao,et al.  Increased plasma endothelin level in patients with essential hypertension. , 1990, The New England journal of medicine.

[29]  M. Yanagisawa,et al.  INCREASED PLASMA CONCENTRATIONS OF ENDOTHELIN-1 AND BIG ENDOTHELIN-1 IN ACUTE MYOCARDIAL INFARCTION , 1989, The Lancet.

[30]  Sadao Kimura,et al.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells , 1988, Nature.

[31]  T. Lüscher,et al.  Angiotensin II increases vascular and renal endothelin-1 and functional endothelin converting enzyme activity in vivo: role of ETA receptors for endothelin regulation. , 1997, Biochemical and biophysical research communications.

[32]  C. Ferri,et al.  Circulating endothelin-1 levels in lean non-insulin-dependent diabetic patients. Influence of ACE inhibition. , 1995, American journal of hypertension.

[33]  K. Usadel,et al.  Increased plasma levels of endothelin in diabetic patients with hypertension. , 1992, American journal of hypertension.